Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center

[1]  L. Kiemeney,et al.  Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. , 2018, European urology.

[2]  A. Hartmann,et al.  Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations. , 2018, European urology.

[3]  A. Briganti,et al.  Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO). , 2018, European urology.

[4]  R. Huddart,et al.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). , 2018, European urology.

[5]  N. Lawrentschuk,et al.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis , 2018, World Journal of Urology.

[6]  R. Breau,et al.  Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta‐analysis , 2018, BJU international.

[7]  Adam T Froemming,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer. , 2018, Journal of the American College of Radiology.

[8]  S. Silverman,et al.  Bladder cancer local staging: multiparametric MRI performance following transurethral resection , 2018, Abdominal Radiology.

[9]  Jin Wang,et al.  The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. , 2017, Radiology.

[10]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[11]  M. Babjuk,et al.  Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. , 2017, European urology.

[12]  J. Cho,et al.  Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis. , 2017, European journal of radiology.

[13]  H. Herr.  Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. , 2017, European urology.

[14]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[15]  Carlo Catalano,et al.  An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer , 2017, European Radiology.

[16]  Yan Guo,et al.  Comparison of Early Submucosal Enhancement and Tumor Stalk in Staging Bladder Urothelial Carcinoma. , 2016, AJR. American journal of roentgenology.

[17]  P. Brenner,et al.  Repeat transurethral resection for non‐muscle‐invasive bladder cancer: a contemporary series , 2016, BJU international.

[18]  L. Kiemeney,et al.  Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. , 2015, European journal of cancer.

[19]  Baris Turkbey,et al.  Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. , 2015, Radiology.

[20]  Jian Guan,et al.  Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. , 2015, AJR. American journal of roentgenology.

[21]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[22]  J. Birkmeyer,et al.  Provider treatment intensity and outcomes for patients with early-stage bladder cancer. , 2009, Journal of the National Cancer Institute.

[23]  Yuta Shibamoto,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.

[24]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[25]  Adam T Froemming,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer. , 2018, Journal of the American College of Radiology : JACR.

[26]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[27]  Yair Lotan,et al.  Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. , 2007, European urology.